Report Detail

Other Global Pneumonia Market Size, Status and Forecast 2019-2025

  • RnM3398136
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 96 pages
  • |
  • QYResearch
  • |
  • Other

Global Pneumonia Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pneumonia Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drugs
      • 1.4.3 Vaccines
      • 1.4.4 Oxygen Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Pneumonia Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pneumonia Market Size
    • 2.2 Pneumonia Growth Trends by Regions
      • 2.2.1 Pneumonia Market Size by Regions (2014-2025)
      • 2.2.2 Pneumonia Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pneumonia Market Size by Manufacturers
      • 3.1.1 Global Pneumonia Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pneumonia Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pneumonia Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pneumonia Key Players Head office and Area Served
    • 3.3 Key Players Pneumonia Product/Solution/Service
    • 3.4 Date of Enter into Pneumonia Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pneumonia Market Size by Type (2014-2019)
    • 4.2 Global Pneumonia Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pneumonia Market Size (2014-2019)
    • 5.2 Pneumonia Key Players in United States
    • 5.3 United States Pneumonia Market Size by Type
    • 5.4 United States Pneumonia Market Size by Application

    6 Europe

    • 6.1 Europe Pneumonia Market Size (2014-2019)
    • 6.2 Pneumonia Key Players in Europe
    • 6.3 Europe Pneumonia Market Size by Type
    • 6.4 Europe Pneumonia Market Size by Application

    7 China

    • 7.1 China Pneumonia Market Size (2014-2019)
    • 7.2 Pneumonia Key Players in China
    • 7.3 China Pneumonia Market Size by Type
    • 7.4 China Pneumonia Market Size by Application

    8 Japan

    • 8.1 Japan Pneumonia Market Size (2014-2019)
    • 8.2 Pneumonia Key Players in Japan
    • 8.3 Japan Pneumonia Market Size by Type
    • 8.4 Japan Pneumonia Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pneumonia Market Size (2014-2019)
    • 9.2 Pneumonia Key Players in Southeast Asia
    • 9.3 Southeast Asia Pneumonia Market Size by Type
    • 9.4 Southeast Asia Pneumonia Market Size by Application

    10 India

    • 10.1 India Pneumonia Market Size (2014-2019)
    • 10.2 Pneumonia Key Players in India
    • 10.3 India Pneumonia Market Size by Type
    • 10.4 India Pneumonia Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pneumonia Market Size (2014-2019)
    • 11.2 Pneumonia Key Players in Central & South America
    • 11.3 Central & South America Pneumonia Market Size by Type
    • 11.4 Central & South America Pneumonia Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pneumonia Introduction
      • 12.1.4 Pfizer Revenue in Pneumonia Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 GlaxoSmithKline(GSK)
      • 12.2.1 GlaxoSmithKline(GSK) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pneumonia Introduction
      • 12.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2014-2019)
      • 12.2.5 GlaxoSmithKline(GSK) Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pneumonia Introduction
      • 12.3.4 Merck Revenue in Pneumonia Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pneumonia Introduction
      • 12.4.4 Novartis Revenue in Pneumonia Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Sanofi
      • 12.5.1 Sanofi Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pneumonia Introduction
      • 12.5.4 Sanofi Revenue in Pneumonia Business (2014-2019)
      • 12.5.5 Sanofi Recent Development
    • 12.6 Eli Lilly
      • 12.6.1 Eli Lilly Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pneumonia Introduction
      • 12.6.4 Eli Lilly Revenue in Pneumonia Business (2014-2019)
      • 12.6.5 Eli Lilly Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
      Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
      In 2018, the global Pneumonia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pneumonia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pneumonia development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      GlaxoSmithKline(GSK)
      Merck
      Novartis
      Sanofi
      Eli Lilly
      ...

      Market segment by Type, the product can be split into
      Drugs
      Vaccines
      Oxygen Therapy

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pneumonia status, future forecast, growth opportunity, key market and key players.
      To present the Pneumonia development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pneumonia are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Pneumonia . Industry analysis & Market Report on Pneumonia is a syndicated market report, published as Global Pneumonia Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pneumonia market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,137.42
      4,706.13
      6,274.83
      3,474.24
      5,211.36
      6,948.48
      421,777.20
      632,665.80
      843,554.40
      268,194.03
      402,291.05
      536,388.06
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report